Silexion Therapeutics Corp

Silexion Therapeutics Corp (SLXN) has registered zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in our near-term monitoring window. However, absence of recent events does not indicate overall risk profile—our 90-day snapshot captures limited visibility into capital structure pressures, equity dilution trends, or financing dependency patterns common in biotech. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scoring, maps financing history and burn rate context, and surfaces AI-flagged risk signals across the complete disclosure record. The full $49 Report adds quantified dilution risk, 12-month event history, financing runway analysis, and comprehensive risk scoring.